These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
53 related articles for article (PubMed ID: 6277289)
1. A review of the antiemetic use of delta-9-tetrahydrocannabinol and prescribing requirements. Nyman JV; Fritz WL Ariz Med; 1982 Jan; 39(1):38-43. PubMed ID: 6277289 [No Abstract] [Full Text] [Related]
2. Delta-9-tetrahydrocannabinol as an antiemetic. Anderson PO; McGuire GG Am J Hosp Pharm; 1981 May; 38(5):639-46. PubMed ID: 6269423 [TBL] [Abstract][Full Text] [Related]
3. An antiemetic drug with a difference. Hopkins S Nurs Mirror; 1984 May; 158(19):21-2. PubMed ID: 6328454 [No Abstract] [Full Text] [Related]
4. Nabilone as an antiemetic. Fox FJ N Engl J Med; 1979 Sep; 301(13):728. PubMed ID: 481477 [No Abstract] [Full Text] [Related]
5. Antiemetic therapy: a review of recent studies and a report of a random assignment trial comparing metoclopramide with delta-9-tetrahydrocannabinol. Gralla RJ; Tyson LB; Bordin LA; Clark RA; Kelsen DP; Kris MG; Kalman LB; Groshen S Cancer Treat Rep; 1984 Jan; 68(1):163-72. PubMed ID: 6318993 [No Abstract] [Full Text] [Related]
6. Tetrahydrocannabinol as an antiemetic for cancer patients. Earhart RH; Buchanan-Davidson DJ Wis Med J; 1980 Mar; 79(3):47-8. PubMed ID: 6244707 [No Abstract] [Full Text] [Related]
7. [Medical applications of dronabinol]. Hennemann A Med Monatsschr Pharm; 2002 Nov; 25(11):369-72. PubMed ID: 12474343 [No Abstract] [Full Text] [Related]
9. Intractable nausea and vomiting due to gastrointestinal mucosal metastases relieved by tetrahydrocannabinol (dronabinol). Gonzalez-Rosales F; Walsh D J Pain Symptom Manage; 1997 Nov; 14(5):311-4. PubMed ID: 9392925 [TBL] [Abstract][Full Text] [Related]
10. Delta-9-tetrahydrocannabinol (THC) as an antiemetic. Kluin-Nelemans JC; Meuwissen OJ; Nelemans FA; Maes RA N Engl J Med; 1980 Jun; 302(24):1364-5. PubMed ID: 6246424 [No Abstract] [Full Text] [Related]
11. The effects of cannabidiol and tetrahydrocannabinol on motion-induced emesis in Suncus murinus. Cluny NL; Naylor RJ; Whittle BA; Javid FA Basic Clin Pharmacol Toxicol; 2008 Aug; 103(2):150-6. PubMed ID: 18816298 [TBL] [Abstract][Full Text] [Related]
12. Nabilone as an antiemetic. Baker JJ; Lokey JL; Price NA; Winokur SH; Bowen J; Taylor A N Engl J Med; 1979 Sep; 301(13):728. PubMed ID: 481476 [No Abstract] [Full Text] [Related]
13. Modification of the pharmacokinetics of high-dose cyclophosphamide and cisplatin by antiemetics. Cagnoni PJ; Matthes S; Day TC; Bearman SI; Shpall EJ; Jones RB Bone Marrow Transplant; 1999 Jul; 24(1):1-4. PubMed ID: 10435726 [TBL] [Abstract][Full Text] [Related]
14. Treatment of Tourette's syndrome with Delta 9-tetrahydrocannabinol (THC): a randomized crossover trial. Müller-Vahl KR; Schneider U; Koblenz A; Jöbges M; Kolbe H; Daldrup T; Emrich HM Pharmacopsychiatry; 2002 Mar; 35(2):57-61. PubMed ID: 11951146 [TBL] [Abstract][Full Text] [Related]
15. Comparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: a multicenter, phase III, randomized, double-blind, placebo-controlled clinical trial from the Cannabis-In-Cachexia-Study-Group. ; Strasser F; Luftner D; Possinger K; Ernst G; Ruhstaller T; Meissner W; Ko YD; Schnelle M; Reif M; Cerny T J Clin Oncol; 2006 Jul; 24(21):3394-400. PubMed ID: 16849753 [TBL] [Abstract][Full Text] [Related]
16. [Randomized comparative trial of a new anti-emetic: nabilone, in cancer patients treated with cisplatin]. George M; Pejovic MH; Thuaire M; Kramar A; Wolff JP Biomed Pharmacother; 1983; 37(1):24-7. PubMed ID: 6311306 [TBL] [Abstract][Full Text] [Related]
17. Delta-9-tetrahydrocannabinol (THC) as an antiemetic. Huguley CM N Engl J Med; 1980 Jun; 302(24):1363-4. PubMed ID: 6246422 [No Abstract] [Full Text] [Related]
19. Use of medical marijuana for treatment of severe intractable nausea after laparoscopic Roux-en-Y gastric bypass surgery. Merriman AR; Oliak DA Surg Obes Relat Dis; 2008; 4(4):550-1. PubMed ID: 18226978 [No Abstract] [Full Text] [Related]